CMS releases details on billing for expanded use of Moderna, J&J boosters

The Centers for Medicare & Medicaid Services Friday released Medicare Part B billing codes and payment allowances for reporting and administering single booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines to eligible adults as authorized Oct. 22 by the Food and Drug Administration.

Authorized COVID-19 booster doses are covered without cost sharing for eligible Medicare, Medicaid, Children's Health Insurance Program and commercial health plan beneficiaries, CMS said.